Planning clinical supplies has become more complex due to increased trial numbers, reduced timelines, recruitment challenges, and globalization. Forecasting and simulation tools help sponsors determine initial supply needs, optimize supply chain strategies, and ensure supplies remain sufficient. An interactive response technology system automates supply management and provides real-time data to forecasting dashboards. These dashboards allow exploring scenarios to prevent issues like stockouts and optimize efficiency. Regularly checking forecasts enables proactive management of clinical supplies.
Researchers, as a whole, tend to underestimate the need for power. I'm just now starting to get it.
I recently gave a brief, easy-to-follow presentation on statistical power, it's importance, and how to go about getting it.
Hope you find it useful.
As part of a series about process capability, this lesson reviews the first 3 steps for following a method for calculating the capability of a process.
I hope it will be simplified and powerful presentation for all. Rather than adding large texts, here you can find image and graphical presentation.
Happy Reading
3rd alex marketing club (pharmaceutical forecasting) dr. ahmed sham'aMahmoud Bahgat
#Mahmoud_Bahgat
#Marketing_Club
Join us by WhatsApp to me 00966568654916
*اشترك في صفحة ال Marketing Club* عالفيسبوك
https://www.facebook.com/MarketingTipsPAGE/
*اشترك في جروب ال Marketing Club* عالفيسبوك
https://www.facebook.com/groups/837318003074869/
*Marketing Club Middle East*
25 Meetings in 6 Cities in 1 year & 2 months
Since October 2015
*We have 6 groups whatsapp*
*for almost 600 marketers*
From all middle east
*since 5 years*
& now 10 more groups
For Marketing Club Lovers as future Marketers
أهم حاجة الشروط
*Only marketers*
From all Industries
No students
*No sales*
*No hotels Reps*
*No restaurants Reps*
*No Travel Agents*
*No Advertising Agencies*
*Many have asked to Attend the Club*
((We Wish All can Attend,But Cant..))
*Criteria of Marketing Club Members*
•••••••••••••••••••••••••••••••••••••
For Better Harmony & Mind set.
*Must be only Marketer*
*Also Previous Marketing experience*
●Business Managers
●Country Manager,GM
●Directors, CEO
Are most welcomed to add Value to us.
■■■■■■■■■■■■■■■■
《 *Unmatched Criteria*》
Not Med Rep,
Not Key Account,
Not Product Specialist,
Not Sales Supervisor,
Not Sales Manager,
●●●●●●●●●●●●●●●●●●
But till you become a marketer
you can join other What'sApp group
*Marketing Lover Future Club Group*
■■■■■■■■■■■■■■■■
《 *Unmatched Criteria*》
For Conflict of Intrest
*Also Can't attend*
If Working in
*Marketing Services Provider*
=not *Hotel* Marketers
=not *Restaurant* Marketers
=not *Advertising* Marketer
=not *Event Manager*
=not *Market Researcher*.
■■■■■■■■■■■■■■■■
■■■■■■■■■■■■■■■■
*this Club for Only Marketers*
Very Soon we will have
*Business Leaders Club*
For Sales Managers & Directors
Will be Not for Markters
●●●●●●●●●●●●●●●●●●●●
■ *Only Marketers* ■
*& EPS Marketing Diploma*
●●●●●●●●●●●●●●●●●●●●
Confirm coming by Pvt WhatsApp
*To know the new Location*
*#Mahmoud_Bahgat*
00966568654916
*#Marketing_Club*
http://goo.gl/forms/RfskGzDslP
*اشترك بصفحة جمعية الصيادلة المصريين* عالفيسبوك
https://lnkd.in/fucnv_5
■ *Bahgat Facbook Page*
https://lnkd.in/fVAdubA
■ *Bahgat Linkedin*
https://lnkd.in/fvDQXuG
■ *Bahgat Twitter*
https://lnkd.in/fmNC72T
■ *Bahgat YouTube Channel*
https://www.Youtube.com /mahmoud bahgat
■ *Bahgat Instagram*
https://lnkd.in/fmWPXrY
■ *Bahgat SnapChat*
https://lnkd.in/f6GR-mR
*#Mahmoud_Bahgat*
*#Legendary_ADLAND*
www.TheLegendary.info
Modeling results from Health Sciences dataJudson Chase
Access to Heath Sciences data by Pharma, Academia, and Government has greater transparency is more generally available than ever before . . . offering untold possibilities through statistics and modeling to predict effect and impact BEFORE decisions are made.
Statistical power lays a foundation for a successful clinical trial, thus affecting all clinical trial professionals. Underpowered studies have a higher risk of not showing a statistically significant effect at the end of the study; whereas overpowered studies can lead to unreasonably large sample sizes, unnecessary risk to patients, and added expense. This webinar will address the basics of statistical power for non-statisticians, highlighting what you need to know about statistical power, how it affects your clinical trial, and what to ask for from your statistician.
Staffing Decision-Making Using Simulation ModelingAlexander Kolker
The use of Management Engineering methodology for
staffing decision-making.
• Part 1 - Quality and Cost: Outpatient Flu Clinic.
• Part 2 - Quality and Cost : Optimal PACU Nursing
Staffing.
• Summary of Fundamental Management Engineering
Nursing research is research that provides evidence used to support nursing practices. Nursing, as an evidence-based area of practice, has been developing since the time of Florence Nightingale to the present day, where many nurses now work as researchers based in universities as well as in the health care setting.
Certified Specialist Business Intelligence (.docxdurantheseldine
Certified Specialist Business
Intelligence (CSBI) Reflection
Part 5 of 6
CSBI Course 5: Business Intelligence and Analytical and Quantitative Skills
● Thinking about the Basics
● The Basic Elements of Experimental Design
● Sampling
● Common Mistakes in Analysis
● Opportunities and Problems to Solve
● The Low Severity Level ED (SL5P) Case Setup as an Example of BI Work
● Meaningful Analytic Structures
Analysis and Statistics
A key aspect of the work of the BI/Analytics consultant is analysis. Analysis can be defined as
how the data is turned into information. Information is the outcome when the data is analyzed
correctly.
Rigorous analysis is having the best chance of creating the sharpest picture of what the data
might reveal and is the product of proper application of statistics and experimental design.
Statistics encompasses a complex and detailed series of disciplines. Statistical concepts are
foundational to all descriptive, predictive and prescriptive analytic applications. However, the
application of simple descriptive statistical calculations yields a great deal of usable information
for transformational decision-making. The value of the information is amplified when using these
same simple statistics within the context of a well-designed experiment.
This module is not designed to teach one statistic. It is designed to place statistical work within
the appropriate context so that it can be leveraged most effectively in driving organizational
performance..
An important review of the basic knowledge for work with descriptive and inferential statistics.
The Basic Elements of Experimental Design
Analytic tools also can provide an enhanced ability to conduct experiments. More than just
allowing analysis of output of activities or processes, experiments can be performed on
processes and the output of processes. Experimenting on processes is a movement beyond
the traditional r.
Researchers, as a whole, tend to underestimate the need for power. I'm just now starting to get it.
I recently gave a brief, easy-to-follow presentation on statistical power, it's importance, and how to go about getting it.
Hope you find it useful.
As part of a series about process capability, this lesson reviews the first 3 steps for following a method for calculating the capability of a process.
I hope it will be simplified and powerful presentation for all. Rather than adding large texts, here you can find image and graphical presentation.
Happy Reading
3rd alex marketing club (pharmaceutical forecasting) dr. ahmed sham'aMahmoud Bahgat
#Mahmoud_Bahgat
#Marketing_Club
Join us by WhatsApp to me 00966568654916
*اشترك في صفحة ال Marketing Club* عالفيسبوك
https://www.facebook.com/MarketingTipsPAGE/
*اشترك في جروب ال Marketing Club* عالفيسبوك
https://www.facebook.com/groups/837318003074869/
*Marketing Club Middle East*
25 Meetings in 6 Cities in 1 year & 2 months
Since October 2015
*We have 6 groups whatsapp*
*for almost 600 marketers*
From all middle east
*since 5 years*
& now 10 more groups
For Marketing Club Lovers as future Marketers
أهم حاجة الشروط
*Only marketers*
From all Industries
No students
*No sales*
*No hotels Reps*
*No restaurants Reps*
*No Travel Agents*
*No Advertising Agencies*
*Many have asked to Attend the Club*
((We Wish All can Attend,But Cant..))
*Criteria of Marketing Club Members*
•••••••••••••••••••••••••••••••••••••
For Better Harmony & Mind set.
*Must be only Marketer*
*Also Previous Marketing experience*
●Business Managers
●Country Manager,GM
●Directors, CEO
Are most welcomed to add Value to us.
■■■■■■■■■■■■■■■■
《 *Unmatched Criteria*》
Not Med Rep,
Not Key Account,
Not Product Specialist,
Not Sales Supervisor,
Not Sales Manager,
●●●●●●●●●●●●●●●●●●
But till you become a marketer
you can join other What'sApp group
*Marketing Lover Future Club Group*
■■■■■■■■■■■■■■■■
《 *Unmatched Criteria*》
For Conflict of Intrest
*Also Can't attend*
If Working in
*Marketing Services Provider*
=not *Hotel* Marketers
=not *Restaurant* Marketers
=not *Advertising* Marketer
=not *Event Manager*
=not *Market Researcher*.
■■■■■■■■■■■■■■■■
■■■■■■■■■■■■■■■■
*this Club for Only Marketers*
Very Soon we will have
*Business Leaders Club*
For Sales Managers & Directors
Will be Not for Markters
●●●●●●●●●●●●●●●●●●●●
■ *Only Marketers* ■
*& EPS Marketing Diploma*
●●●●●●●●●●●●●●●●●●●●
Confirm coming by Pvt WhatsApp
*To know the new Location*
*#Mahmoud_Bahgat*
00966568654916
*#Marketing_Club*
http://goo.gl/forms/RfskGzDslP
*اشترك بصفحة جمعية الصيادلة المصريين* عالفيسبوك
https://lnkd.in/fucnv_5
■ *Bahgat Facbook Page*
https://lnkd.in/fVAdubA
■ *Bahgat Linkedin*
https://lnkd.in/fvDQXuG
■ *Bahgat Twitter*
https://lnkd.in/fmNC72T
■ *Bahgat YouTube Channel*
https://www.Youtube.com /mahmoud bahgat
■ *Bahgat Instagram*
https://lnkd.in/fmWPXrY
■ *Bahgat SnapChat*
https://lnkd.in/f6GR-mR
*#Mahmoud_Bahgat*
*#Legendary_ADLAND*
www.TheLegendary.info
Modeling results from Health Sciences dataJudson Chase
Access to Heath Sciences data by Pharma, Academia, and Government has greater transparency is more generally available than ever before . . . offering untold possibilities through statistics and modeling to predict effect and impact BEFORE decisions are made.
Statistical power lays a foundation for a successful clinical trial, thus affecting all clinical trial professionals. Underpowered studies have a higher risk of not showing a statistically significant effect at the end of the study; whereas overpowered studies can lead to unreasonably large sample sizes, unnecessary risk to patients, and added expense. This webinar will address the basics of statistical power for non-statisticians, highlighting what you need to know about statistical power, how it affects your clinical trial, and what to ask for from your statistician.
Staffing Decision-Making Using Simulation ModelingAlexander Kolker
The use of Management Engineering methodology for
staffing decision-making.
• Part 1 - Quality and Cost: Outpatient Flu Clinic.
• Part 2 - Quality and Cost : Optimal PACU Nursing
Staffing.
• Summary of Fundamental Management Engineering
Nursing research is research that provides evidence used to support nursing practices. Nursing, as an evidence-based area of practice, has been developing since the time of Florence Nightingale to the present day, where many nurses now work as researchers based in universities as well as in the health care setting.
Certified Specialist Business Intelligence (.docxdurantheseldine
Certified Specialist Business
Intelligence (CSBI) Reflection
Part 5 of 6
CSBI Course 5: Business Intelligence and Analytical and Quantitative Skills
● Thinking about the Basics
● The Basic Elements of Experimental Design
● Sampling
● Common Mistakes in Analysis
● Opportunities and Problems to Solve
● The Low Severity Level ED (SL5P) Case Setup as an Example of BI Work
● Meaningful Analytic Structures
Analysis and Statistics
A key aspect of the work of the BI/Analytics consultant is analysis. Analysis can be defined as
how the data is turned into information. Information is the outcome when the data is analyzed
correctly.
Rigorous analysis is having the best chance of creating the sharpest picture of what the data
might reveal and is the product of proper application of statistics and experimental design.
Statistics encompasses a complex and detailed series of disciplines. Statistical concepts are
foundational to all descriptive, predictive and prescriptive analytic applications. However, the
application of simple descriptive statistical calculations yields a great deal of usable information
for transformational decision-making. The value of the information is amplified when using these
same simple statistics within the context of a well-designed experiment.
This module is not designed to teach one statistic. It is designed to place statistical work within
the appropriate context so that it can be leveraged most effectively in driving organizational
performance..
An important review of the basic knowledge for work with descriptive and inferential statistics.
The Basic Elements of Experimental Design
Analytic tools also can provide an enhanced ability to conduct experiments. More than just
allowing analysis of output of activities or processes, experiments can be performed on
processes and the output of processes. Experimenting on processes is a movement beyond
the traditional r.
Using Investigative Analytics to Speed New Drugs to MarketCognizant
Investigative analytics - covering exploratory data analysis (EDA) and inferential statistics - is a powerful, data-driven methodology for uncovering discrepancies in reports from clinical trials, and thus can help streamline and improve the trial process and accelerate the transition from molecule to medicine.
MULTI MODEL DATA MINING APPROACH FOR HEART FAILURE PREDICTIONIJDKP
Developing predictive modelling solutions for risk estimation is extremely challenging in health-care
informatics. Risk estimation involves integration of heterogeneous clinical sources having different
representation from different health-care provider making the task increasingly complex. Such sources are
typically voluminous, diverse, and significantly change over the time. Therefore, distributed and parallel
computing tools collectively termed big data tools are in need which can synthesize and assist the physician
to make right clinical decisions. In this work we propose multi-model predictive architecture, a novel
approach for combining the predictive ability of multiple models for better prediction accuracy. We
demonstrate the effectiveness and efficiency of the proposed work on data from Framingham Heart study.
Results show that the proposed multi-model predictive architecture is able to provide better accuracy than
best model approach. By modelling the error of predictive models we are able to choose sub set of models
which yields accurate results. More information was modelled into system by multi-level mining which has
resulted in enhanced predictive accuracy.
Lung cancer disease analyzes using pso based fuzzy logic systemeSAT Journals
Abstract
Main objective of this paper to improve accuracy of lung cancer disease investigation utilizing molecule swarm enhancement
(PSO) in combination with fuzzy expert system. This paper briefly a introduce fuzzy expert systems and this proposed scheme
compared with related methods. Experimental results of the proposed system simulated by MATLAB 2014.
This article provides basics of the statistical techniques of Sampling and Sampling Distribution. Useful for students and scholars involved the research work in the field of humanities.
As per EU MDR, Post Marketing Clinical Follow-up (PMCF) is a continuous process where device manufacturers need to proactively collect and evaluate clinical data of the device when it is used as per the intended purpose. EU MDR gives more emphasize on PMCF data to confirm the safety and performance of the device throughout its expected lifetime, ensure continued acceptability of identified risks and detect emerging risks based on factual evidence.
Enhanced Detection System for Trust Aware P2P Communication NetworksEditor IJCATR
Botnet is a number of computers that have been set up to forward transmissions to other computers unknowingly to the user
of the system and it is most significant to detect the botnets. However, peer-to-peer (P2P) structured botnets are very difficult to detect
because, it doesn’t have any centralized server. In this paper, we deliver an infrastructure of P2P that will improve the trust of the peers
and its data. In order to identify the botnets we provide a technique called data provenance integrity. It will ensure the correct origin or
source of information and prevents opponents from using host resources. A reputation based trust model is used for selecting the
trusted peer. In this model, each peer has a reputation value which is calculated based on its past activity. Here a hash table is used for
efficient file searching and data stored in it is based on the reputation value.
C omparative S tudy of D iabetic P atient D ata’s U sing C lassification A lg...Editor IJCATR
Data mining refers to extracting knowledge from large amount of data. Real life data mining approaches are
interesting because they often present a different se
t of problems for
diabetic
patient’s
data
.
The
research area to solve
various problems and classification is one of main problem in the field. The research describes algorithmic discussion of J48
,
J48 Graft, Random tree, REP, LAD. Here used to compare the
performance of computing time, correctly classified
instances, kappa statistics, MAE, RMSE, RAE, RRSE and
to find the error rate measurement for different classifiers in
weka .In this paper the
data
classification is diabetic patients data set is develope
d by collecting data from hospital repository
consists of 1865 instances with different attributes. The instances in the dataset are two categories of blood tests, urine t
ests.
Weka tool is used to classify the data is evaluated using 10 fold cross validat
ion and the results are compared. When the
performance of algorithms
,
we found J48 is better algorithm in most of the cases
Comparative Study of Diabetic Patient Data’s Using Classification Algorithm i...Editor IJCATR
Data mining refers to extracting knowledge from large amount of data. Real life data mining approaches are
interesting because they often present a different set of problems for diabetic patient’s data. The research area to solve
various problems and classification is one of main problem in the field. The research describes algorithmic discussion of J48,
J48 Graft, Random tree, REP, LAD. Here used to compare the performance of computing time, correctly classified
instances, kappa statistics, MAE, RMSE, RAE, RRSE and to find the error rate measurement for different classifiers in
weka .In this paper the data classification is diabetic patients data set is developed by collecting data from hospital repository
consists of 1865 instances with different attributes. The instances in the dataset are two categories of blood tests, urine tests.
Weka tool is used to classify the data is evaluated using 10 fold cross validation and the results are compared. When the
performance of algorithms, we found J48 is better algorithm in most of the cases.
ICU Patient Deterioration Prediction : A Data-Mining Approachcsandit
A huge amount of medical data is generated every da
y, which presents a challenge in analysing
these data. The obvious solution to this challenge
is to reduce the amount of data without
information loss. Dimension reduction is considered
the most popular approach for reducing
data size and also to reduce noise and redundancies
in data. In this paper, we investigate the
effect of feature selection in improving the predic
tion of patient deterioration in ICUs. We
consider lab tests as features. Thus, choosing a su
bset of features would mean choosing the
most important lab tests to perform. If the number
of tests can be reduced by identifying the
most important tests, then we could also identify t
he redundant tests. By omitting the redundant
tests, observation time could be reduced and early
treatment could be provided to avoid the risk.
Additionally, unnecessary monetary cost would be av
oided. Our approach uses state-of-the-art
feature selection for predicting ICU patient deteri
oration using the medical lab results. We
apply our technique on the publicly available MIMIC
-II database and show the effectiveness of
the feature selection. We also provide a detailed a
nalysis of the best features identified by our
approach.
ICU PATIENT DETERIORATION PREDICTION: A DATA-MINING APPROACHcscpconf
A huge amount of medical data is generated every day, which presents a challenge in analysing
these data. The obvious solution to this challenge is to reduce the amount of data without
information loss. Dimension reduction is considered the most popular approach for reducing
data size and also to reduce noise and redundancies in data. In this paper, we investigate the
effect of feature selection in improving the prediction of patient deterioration in ICUs. We
consider lab tests as features. Thus, choosing a subset of features would mean choosing the
most important lab tests to perform. If the number of tests can be reduced by identifying the
most important tests, then we could also identify the redundant tests. By omitting the redundant
tests, observation time could be reduced and early treatment could be provided to avoid the risk.
Additionally, unnecessary monetary cost would be avoided. Our approach uses state-of-the-art
feature selection for predicting ICU patient deterioration using the medical lab results. We
apply our technique on the publicly available MIMIC-II database and show the effectiveness of
the feature selection. We also provide a detailed analysis of the best features identified by our
approach.
A Lean Six Sigma Case Study
If you want to prosper for a year, grow rice. If you want to prosper for a decade, plant trees. If
you want to prosper for a century, grow people -- a wise old farmer reflecting back on a life
of toil in the soil
PROJECT DESCRIPTION
The following Lean Six Sigma case study will reflect a real-life healthcare problem with
Continuous Improvement and Lean Six Sigma Tools to show how some of the tools are put into
place in the real world. The object of this project is your appropriate use of Lean Six Sigma
tools and the data provided. Project completion is required to pass the course. Project
assignments are assessed on a Complete/Incomplete basis. Each Phase of the DMAIC process in
the Project has an assignment. Assignments must be submitted to the instructor by the end of the
week corresponding to the DMAIC Phase. The exception is the week 8 or Control phase
assignment which needs to be submitted early in the last week of the course to allow grading.
The Instructor will determine if the student has submitted a Project assignment that is Complete.
If the assignment is Incomplete, there will be interaction between the Instructor and student until
the assignment is Complete. All project assignments must be assessed as Complete for the
student to pass the course. An Incomplete project will result in a Failing grade for the course.
Student Case Study
Case Study:
Process Improvement –
Reduction in Wait Time for
Patients in a Doctor Office
Executive Summary
Dr. Deasley is a popular Doctor in Tampa, Florida specializing in primary care. He spends a great deal of
time with each of his patients, typically, 45 minutes to one (1) hour. As a result, there are many other
patients waiting in the waiting room who become impatient at the long wait time. The Doctor has hours
every day except Wednesdays. He has Hospital Clinic on Wednesdays and does not have office hours.
Dr. Deasley’s office hours are 7:30 AM to 5:30 PM (patients can be scheduled up until 5:30 PM) on
Tuesdays and Thursdays and 9:30 AM to 7:30 PM (patients can be scheduled up until 7:30 PM) on
Mondays and Fridays. He does Hospital Rounds from 6:00 AM to 8:00 AM. He conducts patient call
backs between patients, during his lunch hour and after office hours. We triage the calls so he gets back
to more seriously sick patients first. However, sometimes he doesn’t call back non-emergencies until the
next AM. Dr. Deasley is becomes overbooked because he likes to have 10 patients scheduled per day.
However, due to time constraints he frequently needs to rebook patients he is unable to see due to time
constraints.
Dr. Deasley’s patients and staff love him for his patience and attention. But, several long term patients
have left his practice because of this issue. This has resulted in a decrease in revenue for the office. In
addition, his office is experiencing a rather high rate of staff turnover. S ...
Machine Learning and the Value of Health TechnologiesCovance
Machine learning can be applied through the development of algorithms that can unravel or "learn" complex associations in large datasets with limited human input. These algorithms are capable of making predictions that go beyond our capabilities as humans and they can process and analyze more possibilities. Machine learning may help us find answers to questions that we didn't even think of in the past, revealing evidence previously hidden among the data. We can use these methods to dig up imperceptible patterns and allow health technologies to be used at the right time and for the right patient population. (A4 Version)
1. As the world’s leading IRT specialist,
We see things others don’t.
Clinical Supply Chain Forecasting
and Simulation
Cenduit White Paper Series: Issue 4
Accurate forecasting of clinical supplies has become increasingly important in the past several years as planning the
amount of study drug and other materials required to complete a trial has grown in complexity. Key drivers adding
to this complexity include increased numbers of trials, reduced start-up timelines, patient recruitment challenges,
globalization leading to more distant clinical sites and a variety of regulatory requirements, and escalating costs
for investigational drugs and comparators.[1]
To meet these challenges, sponsors
have turned to a variety of forecasting methods ranging from manual spreadsheet
calculations to software that enables sophisticated supply chain modeling.
Well-designed forecasting solutions provide real Business Intelligence (BI) that
enables data-driven decisions when planning, running and closing a study. And
IRT Systems provide the ideal platform to collect and feed real-world information
into the forecasting solutions.
When planning a trial, forecasting solutions help sponsors to determine the
amount of medications and other supplies they will need to manufacture and
package. Using modeling techniques, sponsors and CROs can also plan an effective
supply chain strategy. Forecasting is also valuable during the execution of a study
Planning the amount of study
drug and other materials
required to complete a trial
has grown in complexity.
Key drivers include increased
numbers of trials, reduced
start-up timelines, patient
recruitment challenges, and
globalization
2. to make sure that the supply chain strategy remains on track and when necessary, allows sponsors to take
proactive measures to ensure ongoing success. As a study is drawing to a close, forecasting helps to ensure not
only that there will be enough supplies to complete the trial, but also that a minimal amount of medication will
be left over at sites and depots, thereby minimizing wasted supplies and the associated costs. At times sponsors
and vendors have also employed simulation techniques for the same purposes.
This paper will discuss how clinical supply forecasting is typically used in planning and running a trial. It will also
describe what is typically meant by the terms “simulation” and “forecasting.” First, it is important to establish the
main goals of simulation and forecasting.
Goals of Clinical Supplies Forecasting and Simulation
The most important objectives of forecasting and simulation are 1) to plan for the initial supplies that will be needed
for a trial, 2) to optimize the entire supply chain strategy, 3) to ensure that the supply strategy remains on track
until the trial is complete and 4) to minimize and mitigate any risk in the supply chain (see Table 1). Forecasting
Cenduit Forecasting White Paper
2
Table 1: Goals of Forecasting and Simulation
3. 3
enables Clinical Supply Managers (CSMs) to make data-driven decisions and to gain insights into the supply needs
of a trial by exploring various scenarios. It also allows them to change various parameters to see what may happen
in the real world. For example, a CSM may run a forecast to see if adding new sites to the study will cause a shortfall
in any supplies. The CSM may also model a number of “what-if” scenarios to see what might happen if sites in
some regions recruit patients rapidly while other regions have slower enrolment. By modeling the future this way,
supply managers gain insights into the supply chain and can proactively make adjustments before issues arise.
Defining Forecasting and Simulation
Forecasting refers to techniques to predict future outcomes based on past events and professional insights gained
from observation. Methods usually rely on mathematical formulas based on facts, observed trends, data models
and at times, expert opinions. Perhaps the simplest analogy is the weather forecast. There are different weather
models which generally produce similar, but not identical, predictions. This is evident when one checks several
different websites for the next day’s weather and minor variations are observed. Of course, the farther into the
future one looks, the more the predictions of each model will vary and the more the reliability is reduced.[2]
So when planning an important event, it is wise to check the forecast regularly as the day draws nearer. The same
holds true in trial supply forecasts.
As a clinical trial is launched into the real world, many of the assumptions used during the planning phase, including
any pre-study simulations, may change. For example, if recruitment rates are slower than anticipated, the study
will experience delays and will likely run longer than anticipated. Will some drug expire during the study as a
result? Will another packaging run be required? Will more sites be needed to
recruit additional patients? These are just a few factors that will affect the supply
chain and the initial forecasts.
Simulation is a means to generate forecasts and to reveal meaningful details about
the system being modeled. It is used to model the real world using probability
distributions and allowing for uncertainty by using ranges of values for factors that
may vary. Then the model is run many times with each iteration producing different
results due to the built-in variability of some parameters. The results of each run
are then saved and aggregated to produce a report that typically shows the average
(mean and/or median) outcome, standard deviation, range (highest and lowest
values) and similar descriptive statistics. Such reports provide insights into the
system being modeled. As a side point, the weather forecasts mentioned earlier,
are actually the results of simulations; however, only the most probable forecast from the simulations is reported in
the form of the expected high and low temperature, humidity level and pressure. Details, such as the temperature
ranges and potential variations observed in the simulation results, are omitted.
To further illustrate how simulation works, suppose we were setting up a model to simulate coin tosses. We would
set up the simulation with an equal probability of getting a head or tail on each toss. If we run the simulation once
Cenduit Forecasting White Paper
Simulation is a means to
generate forecasts and to
reveal meaningful details
about the system being
modeled. It is used to
model the real world using
probability distributions
and allowing for uncertainty
by using ranges of values for
factors that may vary
4. 4
and the result is “heads,” that would represent one possible outcome, but would provide little additional
information. Now suppose we simulate 100 coin tosses and aggregate the results. We could then report the
average number of iterations where the result was heads along with the standard deviation. We could also answer
other questions such as: What was the highest number of consecutive heads? How often did the simulation
generate two consecutive tails? Thus, even this simple simulation experiment would provide information about
potential outcomes that may help to anticipate what would happen in the real world.
Applying these concepts to the clinical supply chain, a simulation model may be set up with a number of param-
eters, some allowing for variability and others fixed or predetermined. Figure 1 shows the main categories and
key factors that would be included in a forecasting or simulation model. Some fixed parameters would include the
numbers of depots, sites and countries and the study visit and dosing schedule. Other parameters will allow for
variation between runs. Variable factors would include patient recruitment rates, shipping times between
locations and site activation rates. For example, the model may involve varying patient recruitment rates for high
and medium enrolling sites. A high enrolling site might expect between zero and two patients per week during the
recruiting period, while a site with a medium rate might expect between zero and one. During each simulation run,
Cenduit Forecasting White Paper
Analytics & Reporting:
Status & Forecasting
• Strategic Dashboard with live data
• Intelligent Data Mining
• Real-time Material Forecasting
Site and Country Parameters
• Number of Sites
• Recruitment Rates
• Lead Time into Countries
Study Design
• Randomization Algorithm
• IRT Configuration Parameters
• Adaptive Designs/Titrations
Depot Planning
• Depot Hierarchy
• Depot Supply Parameters
• Lead times (depot to depot,
depot to site)
Packaging Configuration
• Expiry Date Management
• Subject Dosing Schedules
• Pack Types
Figure 1: Key Factors in Trial Supply Management
5. 5
the model would then randomly generate and assign patients to sites based on those rates. Next the model would
be run through many iterations and the results would be aggregated allowing the sponsor to answer questions
such as: How long did it take, on average, to recruit all patients into the trial? What were the fastest and slowest
recruiting times in the results? Were there any stock-outs at depots or sites in any
of the runs? What was the average amount of drug left at each depot and site?
The answers to these and similar questions can be valuable in setting up the
clinical supply chain and in making sure that it remains on track during the entire
trial. Since the supply chain for most modern studies is automated using an
Interactive Response Technology (IRT) platform, forecasting results are also very
useful in setting up and configuring the IRT parameters and the real-world data
collected by the IRT can shape ongoing forecasts or new simulations.
Forecasting with Interactive Response Technology (IRT)
IRT systems have become indispensable tools for managing the clinical supply chain in an efficient and cost-
effective manner. These systems automate the complex processes involved in Randomization and Trial Supply
Management (RTSM) and enable sponsors to save money by minimizing the amount of overage required to run
a trial while simultaneously reducing the number of costly shipments required to move supplies from depot to
site. Achieving such efficiencies requires balancing the very same supply chain factors discussed above and shown
in Figure 1.[3,4]
When running a pre-study forecast, it is good practice to make sure that these factors are aligned
with the IRT system configuration to get the most accurate results possible; however, at times the sponsor may
be planning a manufacturing run even before they have selected their IRT vendor. This is an important reason to
perform ongoing, mid-study forecasts. Additional insights may be gained by repeating the pre-study simulations
using real-world data to update the assumptions made before the study began.
There are additional reasons to perform mid-study forecasts. For example, while some sponsors have developed
their own supply forecasting methods, many are simply spreadsheet calculations that are used to determine the
overall amounts of study drug and comparator that will be needed. Such basic approaches have value when
planning, but they usually have the several limitations. First, they are detached from the actual supply chain
methodology that will be built into a well-constructed IRT system and therefore, do not consider how the system
will optimize the management of study supplies. Second, they rely on baseline assumptions about the study that
may change, such as the expected recruitment rates, number of sites, study duration and so on. Third, many of
these spreadsheet approaches ignore vital factors like expiry date management. For these reasons, more rigor is
needed when forecasting supply needs.
Modern IRT platforms generally include features like built-in intelligent forecasting, standard and ad-hoc reporting
capabilities as well as dashboards and analytics that allow CSMs to explore future supply needs by modeling
“what-if” scenarios. As a study progresses, the IRT holds critical, real-time information about the entire clinical
supply chain. The system not only tracks where every unit of study medication and other supplies are, but is
Cenduit Forecasting White Paper
Forecasting results are also
very useful in setting up and
configuring the IRT parameters
and the real-world data
collected by the IRT can shape
ongoing forecasts or new
simulations.
6. 6
Cenduit Forecasting White Paper
also aware of the future supply requirements based on the visit and dosing schedules, how far each patient has
progressed in the trial, whether any supplies have been damaged in transit and so on. When this information is
exposed to a supply manager via an interactive forecasting dashboard, it creates a powerful and valuable tool
enabling teams to take a proactive approach to managing supplies.
Figure 2 provides an overview of the value of forecasting in the planning and execution of a trial; it also shows
some of the key areas that are typically analyzed and, if necessary, updated. For example, a CSM viewing the
enrollment reports may notice that recruitment is lower than expected in the US, but ahead of schedule in Eastern
Europe. If this trend continues, will the drug supply sent to the Eastern European depot be sufficient? A quick
Figure 2: Value of Forecasting in Planning and Execution of a Clinical Trial
7. 7
Figure 3: What is a Forecasting Dashboard?
Simply put, a Forecasting Dashboard is an interactive, single-page view of the clinical supply chain as it looks at this
instant in time and based on current trends and user controls, how it is expected to look in the future. The dashboard
conveys this information at a glance with easy-to-read graphs, charts, tables and visualizations. It also allows provides
straightforward controls that allow the user to explore what will happen if specific actions are taken or if certain trends
change. For example, the user may model the future by dragging a slider to add investigative sites or to increase or
decrease patient recruitment rates.
Other vital features of a solid Forecasting Dashboard include the ability to look at the supply chain across multiple
trials (pooling supplies) and to drill down to specific regions, countries, depots, sites and so on. The user should also
be able to filter for specific types of materials or medications with a simple click or screen tap. Finally, the user should
be able to save and share the scenarios and views created to help support and document supply chain decisions.
In the sample screenshot shown in this figure, the user has checked the “Forecast” button and is exploring several
what-if scenarios (rather than simply viewing the current status). Using the slide-bar controls, the user is modeling
what would happen if two more sites were activated, if another site per month is added and if the targets for total
patients randomized and number randomized per month are increased. As shown on the line graph, these proposed
changes would immediately affect the current stock levels as additional medication kits would have to be sent to the
newly activated sites and more kits would be needed at existing sites to handle the increased randomizations. (For
example, note that the stock level for medication type “5mg 3 day” falls from current level of 520 kits to about 420
as shown on the middle blue line of the line graph.) Further, this scenario would lead to a stock-out of at least one
medication type by September.
8. look at the forecasting dashboard will provide the answer by showing how long the depot supply will last based
on the current recruitment rate. More than that, the CSM can drill down to individual sites in the region to make
sure the current supply chain strategy will avoid stock-outs at the site level. If a stock-out is predicted, then the
user can set up additional scenarios to see what will prevent the shortfall. For example, they may set up models to
answer questions such as: “If I move supplies from the USA depot to the Eastern European one, will it prevent the
stock-out without creating a similar issue at USA sites? If the recruitment rate slows just a little, will we still have a
stock-out? Will we need another manufacturing run?” (For details, see Figure 3: What is a Forecasting Dashboard?)
By regularly checking the forecasting dashboard, the CSM and other study team members can proactively handle
any potential issues to keep the study supplies on track. They can also make sure that the IRT will continue to
supply every site and patient exactly as needed without wasting supplies.
Conclusion
Planning, tracking and managing the clinical supply chain is critical to the success of any clinical trial. Further,
there are dozens of factors and decisions involved in the ongoing health of the supply chain. Forecasting and
simulation are valuable tools that help a CSM to perform critical planning activities,
such as optimizing the IRT supply chain parameters and making sure ample
supplies are on hand to run the trial. In turn, a fine-tuned supply chain strategy
reduces costs by making efficient use of supplies, reducing waste that is often
caused by overages and by allowing just-in-time shipments when medication is
very expensive or in short supply. Once the study goes live, the CSM can gain
important insights into the supply chain by using current, real-time information
directly from the IRT to look at updated forecasts. If issues are predicted, then
different mitigation plans can be modelled proactively in the forecasting dashboard
to guide the CSM to an effective solution. In this manner, forecasting dashboards
provide meaningful support for data-driven decisions that help to ensure the health, costs and overall performance
of the entire clinical supply chain.
8
Cenduit Forecasting White PaperCenduit Forecasting White Paper
Planning, tracking and
managing the clinical supply
chain is critical to the success
of any clinical trial.
Further, there are dozens of
factors and decisions involved
in the ongoing health of the
supply chain
9. Cenduit Forecasting White Paper
As the world’s leading IRT specialist, we see things others don’t.
•• Bringing together expertise, technology, innovation, and vision
•• Meeting all randomization, trial supply, and patient management needs
•• Seeing exactly what our customers need and how to help them succeed
Contact us, and learn how Cenduit sees things others don’t. email: corp.communication@cenduit.com web: www.cenduit.com
Endnotes
[1] Lamberti, Mary Jo, PhD, “Global Supply Chain Management", Applied Clinical Trials, September 1, 2012.
[2] Kwon, Diana, “Are Europeans Better Than Americans at Forecasting Storms?”, Scientific American, October 1, 2015.
[3,4] “White Paper: Factoring the “What Ifs” into Supply Forecasting: Why Building a Durable Supply Chain Around a
Protocol Is Critical”, Fisher Clinical Services, fisherclinicalservices.com.